These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10833320)
1. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology. Pickering-Brown SM; Owen F; Isaacs A; Snowden J; Varma A; Neary D; Furlong R; Daniel SE; Cairns NJ; Mann DM Exp Neurol; 2000 Jun; 163(2):452-6. PubMed ID: 10833320 [TBL] [Abstract][Full Text] [Related]
2. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Geschwind D; Karrim J; Nelson SF; Miller B Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603 [TBL] [Abstract][Full Text] [Related]
3. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Fabre SF; Forsell C; Viitanen M; Sjögren M; Wallin A; Blennow K; Blomberg M; Andersen C; Wahlund LO; Lannfelt L Exp Neurol; 2001 Apr; 168(2):413-8. PubMed ID: 11259129 [TBL] [Abstract][Full Text] [Related]
4. The evolution and pathology of frontotemporal dementia. Kertesz A; McMonagle P; Blair M; Davidson W; Munoz DG Brain; 2005 Sep; 128(Pt 9):1996-2005. PubMed ID: 16033782 [TBL] [Abstract][Full Text] [Related]
5. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene]. Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827 [TBL] [Abstract][Full Text] [Related]
7. Association between tau H2 haplotype and age at onset in frontotemporal dementia. Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512 [TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
10. APOE and modulation of Alzheimer's and frontotemporal dementia. Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Parsian A; Racette B; Goldsmith LJ; Perlmutter JS Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377 [TBL] [Abstract][Full Text] [Related]
12. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
13. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease. Borroni B; Alberici A; Agosti C; Premi E; Padovani A Int J Geriatr Psychiatry; 2008 Aug; 23(8):796-800. PubMed ID: 18172915 [TBL] [Abstract][Full Text] [Related]
14. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213 [TBL] [Abstract][Full Text] [Related]
15. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease. Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC; Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497 [TBL] [Abstract][Full Text] [Related]
19. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822 [TBL] [Abstract][Full Text] [Related]
20. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]